Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma

Concomitant deregulation of MYC and BCL2 comprises clinically significant, yet poorly characterized biological high-risk feature in diffuse large B-cell lymphoma (DLBCL). To interrogate these lymphomas, we analyzed translocations and protein expression of BCL2, BCL6, and MYC; correlated the findings...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Meriranta, Leo, Pasanen, Annika, Alkodsi, Amjad, Haukka, Jari, Karjalainen-Lindsberg, Marja-Liisa, Leppä, Sirpa
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422114/
https://ncbi.nlm.nih.gov/pubmed/32780847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001727
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars